pt. 1. Disease burden, current treatments, medical needs, and strategic approaches -- pt. 2. Metabolic peculiarities in the trypanosomatid family guiding drug discovery -- pt. 3. Validation and selection of drug targets in kinetoplasts -- pt. 4. Examples of target-based approaches and compounds under consideration.
Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries